IPO investing involves substantial risks. Before applying for any IPO, you must carefully evaluate the following disclosures:
1. Market & Listing Price Volatility
The listed trading price of shares can fall significantly below the issue price on the listing day or in subsequent trading sessions. Broad market conditions, economic shifts, or sector momentum can impact the debut performance negatively.
2. Share Allotment Risk
Submitting an application for an IPO does not guarantee share allotment. In highly oversubscribed issues, retail applications are randomized by the registrar, and you may receive zero allotment or a minor fraction of the requested shares.
3. Grey Market Premium (GMP) Risks
Grey Market Premium (GMP) is completely unofficial and speculative. It can change rapidly, be artificially inflated, or manipulated by offline syndicates. It does not correlate reliably with post-listing long-term returns or listing-day outcomes.
4. Oversubscription Fallacy
High subscription figures (QIB, NII, or retail) indicate short-term demand but do not guarantee listing gains or positive long-term business performance once the company trades on the open market.
5. SME-Specific segment Volatility
SME IPOs pose higher liquidity risks, wider bid-ask spreads, and lower public transparency than mainboard listings. Regulatory bodies like SEBI have issued warnings regarding risk factors in SME companies, advising investors to verify misleading statements.
6. Valuation & Fundamental Risk
IPOs are frequently priced at expensive PE or PB valuations compared to listed peers to maximize proceeds for promoters. The company may have a limited history of operational profitability or cash flows.
7. AI Summary Hallucinations
AI-generated summaries on this website may omit crucial footnotes, risk disclosures, or litigation details from the DRHP/RHP. Users must not rely solely on automated summary outputs.
8. No Suitability Checks
IPO Lens does not evaluate your income, financial goals, risk appetite, or portfolio allocation. You are responsible for consulting a qualified professional to assess the suitability of any IPO investment.